Published in J Clin Virol on December 01, 2004
Lanthanum carbonate decreases PTH gene expression with no hepatotoxicity in uraemic rats. Nephrol Dial Transplant (2006) 2.20
A double-blind clinical trial for treatment of Crohn's disease by oral administration of Alequel, a mixture of autologous colon-extracted proteins: a patient-tailored approach. Am J Gastroenterol (2006) 2.19
Lamivudine therapy for prevention of immunosuppressive-induced hepatitis B virus reactivation in hepatitis B surface antigen carriers. Blood (2002) 1.87
Anti-fibrotic activity of NK cells in experimental liver injury through killing of activated HSC. J Hepatol (2006) 1.86
Reduced dose and duration of peginterferon alfa-2b and weight-based ribavirin in patients with genotype 2 and 3 chronic hepatitis C. J Hepatol (2011) 1.55
Treatment of chronic hepatitis C virus infection via antioxidants: results of a phase I clinical trial. J Clin Gastroenterol (2005) 1.24
Glucocerebroside ameliorates the metabolic syndrome in OB/OB mice. J Pharmacol Exp Ther (2006) 1.16
Glucocerebroside treatment ameliorates ConA hepatitis by inhibition of NKT lymphocytes. Am J Physiol Gastrointest Liver Physiol (2005) 1.03
Suppression of hepatocellular carcinoma growth via oral immune regulation towards tumor-associated antigens is associated with increased NKT and CD8+ lymphocytes. Oncology (2004) 0.97
Prognosis of symptomatic versus asymptomatic autoimmune hepatitis: a study of 68 patients. J Clin Gastroenterol (2002) 0.97
Retracted Amelioration of hepatic fibrosis via beta-glucosylceramide-mediated immune modulation is associated with altered CD8 and NKT lymphocyte distribution. Int Immunol (2007) 0.96
NKT and CD8 lymphocytes mediate suppression of hepatocellular carcinoma growth via tumor antigen-pulsed dendritic cells. Int J Cancer (2003) 0.96
Endocannabinoids affect neurological and cognitive function in thioacetamide-induced hepatic encephalopathy in mice. Neurobiol Dis (2005) 0.96
Hepatic hydrothorax--pathophysiology, diagnosis and treatment--review of the literature. Liver Int (2004) 0.93
Liver abscess in inflammatory bowel disease: report of two cases and review of the literature. J Gastroenterol Hepatol (2004) 0.92
Cannabinoids ameliorate cerebral dysfunction following liver failure via AMP-activated protein kinase. FASEB J (2007) 0.91
Late cytomegalovirus disease following liver transplantation. Transpl Int (2003) 0.91
Gastric stimulation for weight loss. World J Gastroenterol (2012) 0.91
Glycolipids as immune modulatory tools. Mini Rev Med Chem (2006) 0.91
Suppression of hepatocellular carcinoma by transplantation of ex-vivo immune-modulated NKT lymphocytes. Int J Cancer (2005) 0.90
Immunomodulation of experimental colitis via caloric restriction: role of Nk1.1+ T cells. Clin Immunol (2002) 0.90
Point-of-care continuous (13)C-methacetin breath test improves decision making in acute liver disease: results of a pilot clinical trial. World J Gastroenterol (2009) 0.90
Endocannabinoids and liver disease--review. Liver Int (2005) 0.89
The gut mucosa as a site for induction of regulatory T-cells. Curr Pharm Des (2009) 0.89
Adoptive transfer of NK 1.1+ lymphocytes in immune-mediated colitis: a pro-inflammatory or a tolerizing subgroup of cells? Microbes Infect (2005) 0.88
Suppression of hepatocellular carcinoma growth in mice via leptin, is associated with inhibition of tumor cell growth and natural killer cell activation. J Hepatol (2005) 0.87
Cannabinoids and capsaicin improve liver function following thioacetamide-induced acute injury in mice. Am J Gastroenterol (2008) 0.87
Beta-glycosphingolipids improve glucose intolerance and hepatic steatosis of the Cohen diabetic rat. Am J Physiol Endocrinol Metab (2008) 0.87
The role of intrahepatic CD8+ T cell trapping and NK1.1+ cells in liver-mediated immune regulation. Clin Immunol (2004) 0.86
Treatment of chronic hepatitis B virus infection via oral immune regulation toward hepatitis B virus proteins. Am J Gastroenterol (2003) 0.85
Adoptive transfer of ex vivo immune-programmed NKT lymphocytes alleviates immune-mediated colitis. J Leukoc Biol (2003) 0.84
NK 1.1+ T cell: a two-faced lymphocyte in immune modulation of the IL-4/IFN-gamma paradigm. J Clin Immunol (2002) 0.83
The coexistence of Sweet's syndrome and Still's disease--is it merely a coincidence? J Am Acad Dermatol (2004) 0.83
Antioxidant therapy for chronic hepatitis C after failure of interferon: results of phase II randomized, double-blind placebo controlled clinical trial. World J Gastroenterol (2007) 0.83
beta-Glycosphingolipids as immune modulators. J Immunotoxicol (2008) 0.83
Enzyme replacement therapy for mild patients with Gaucher disease. Am J Hematol (2009) 0.83
Role of NK1.1+ and AsGm-1+ cells in oral immunoregulation of experimental colitis. Inflamm Bowel Dis (2003) 0.82
Alleviation of insulin resistance and liver damage by oral administration of Imm124-E is mediated by increased Tregs and associated with increased serum GLP-1 and adiponectin: results of a phase I/II clinical trial in NASH. J Inflamm Res (2012) 0.82
Assessment of insulin resistance by a 13C glucose breath test: a new tool for early diagnosis and follow-up of high-risk patients. Nutr J (2010) 0.81
Induction of oral immune regulation towards liver-extracted proteins for treatment of chronic HBV and HCV hepatitis: results of a phase I clinical trial. Liver Int (2004) 0.81
Induction of immune tolerance: a role for Natural killer T lymphocytes? Liver Int (2005) 0.81
Modulation of intracellular machinery by beta-glycolipids is associated with alteration of NKT lipid rafts and amelioration of concanavalin-induced hepatitis. Mol Immunol (2008) 0.81
A novel 13C-urea breath test device for the diagnosis of Helicobacter pylori infection: continuous online measurements allow for faster test results with high accuracy. J Clin Gastroenterol (2003) 0.81
Inducing oral immune regulation of hepatitis B virus envelope proteins suppresses the growth of hepatocellular carcinoma in mice. Cancer (2002) 0.81
Assessment of liver function in acute or chronic liver disease by the methacetin breath test: a tool for decision making in clinical hepatology. J Breath Res (2009) 0.80
Evaluation of the 13C-octanoate breath test as a surrogate marker of liver damage in animal models. Dig Dis Sci (2010) 0.80
Induction of immune tolerance toward tumor-associated-antigens enables growth of human hepatoma in mice. Int J Cancer (2002) 0.80
Beta-glycosphingolipids-mediated lipid raft alteration is associated with redistribution of NKT cells and increased intrahepatic CD8+ T lymphocyte trapping. J Lipid Res (2008) 0.80
Malignancy after liver transplantation in patients with premalignant conditions. J Clin Gastroenterol (2003) 0.80
Reduced incidence of hyperuricemia, gout, and renal failure following liver transplantation in comparison to heart transplantation: a long-term follow-up study. Transplantation (2004) 0.79
2-Arachidonoylglycerol, an endogenous cannabinoid receptor agonist, in various rat tissues during the evolution of experimental cholestatic liver disease. Prostaglandins Leukot Essent Fatty Acids (2008) 0.79
Air transportation of patients with end-stage liver disease to distant liver transplantation centers. Liver Transpl (2005) 0.79
NKT lymphocyte polarization determined by microenvironment signaling: a role for CD8+ lymphocytes and beta-glycosphingolipids. J Autoimmun (2008) 0.78
Oral administration of Alequel, a mixture of autologous colon-extracted proteins for the treatment of Crohn's disease. Therap Adv Gastroenterol (2010) 0.78
Oral Administration of OKT3 MAb to Patients with NASH, Promotes Regulatory T-cell Induction, and Alleviates Insulin Resistance: Results of a Phase IIa Blinded Placebo-Controlled Trial. J Clin Immunol (2015) 0.77
Development of a scaled up liver device incorporating cryo-preserved pig liver micro-organs. J Hepatol (2004) 0.77
Regulatory role of the pituitary-adrenal axis in experimental colitis: effect of adrenalectomy on the clinical course and the TH1/TH2 immune profile. Inflamm Bowel Dis (2005) 0.77
Beta-glycoglycosphingolipid-induced alterations of the STAT signaling pathways are dependent on CD1d and the lipid raft protein flotillin-2. Am J Pathol (2009) 0.77
Early expression of interferon gamma following oral antigen administration is associated with peripheral tolerance induction. Microbes Infect (2003) 0.77
Oral immune regulation using colitis extracted proteins for treatment of Crohn's disease: results of a phase I clinical trial. World J Gastroenterol (2005) 0.77
Amelioration of experimental colitis by Copaxone is associated with class-II-restricted CD4 immune blocking. Clin Immunol (2005) 0.77
Utility of a 13C-methacetin breath test in evaluating hepatic injury in rats. J Gastroenterol Hepatol (2008) 0.77
Hepatoprotective effect of DT56a is associated with changes in natural killer T cells and regulatory T cells. J Dig Dis (2013) 0.77
Potential role of NKT regulatory cell ligands for the treatment of immune mediated colitis. World J Gastroenterol (2007) 0.77
Decreased STAT-1 phosphorylation by a thio analogue of beta-D-glucosylceramide is associated with altered NKT lymphocyte polarization. Mol Immunol (2009) 0.77
Oral immune regulation: a new mode of therapy against chronic viral infections. Recent Pat Antiinfect Drug Discov (2007) 0.76
Administration of beta-glycolipids overcomes an unfavorable nutritional dependent host milieu: a role for a soy-free diet and natural ligands in intrahepatic CD8+ lymphocyte trapping and NKT cell redistribution. Int Immunopharmacol (2008) 0.76
Towards a bank of cryopreserved hepatocytes: which cell to freeze? J Hepatol (2002) 0.75
Intrahepatic CD8(+) lymphocyte trapping during tolerance induction using mushroom derived formulations: a possible role for liver in tolerance induction. World J Gastroenterol (2008) 0.75
Is presensitization relevant to liver transplantation outcome? Hum Immunol (2002) 0.75
Impaired liver regeneration by β-glucosylceramide is associated with decreased fat accumulation. J Dig Dis (2013) 0.75
Idiopathic liver involvement in Turner syndrome. Isr Med Assoc J (2004) 0.75
Histamine dihydrochloride: actions and efficacy in the treatment of chronic hepatitis C infection. Expert Rev Anti Infect Ther (2006) 0.75
Liver micro-organs transcribe albumin and clotting factors and increase survival of 92% hepatectomized rats. J Hepatol (2003) 0.75
Large solitary splenic diffuse large B cell lymphoma in a hepatitis C virus-infected patient. Isr Med Assoc J (2005) 0.75
[Idiopathic right-sided endocarditis: an uncommon manifestation of pulmonary cavitations]. Harefuah (2009) 0.75
Exacerbation of pulmonary sarcoidosis after liver transplantation. J Clin Gastroenterol (2002) 0.75
[Neurologic complications following liver transplantation]. Harefuah (2002) 0.75
[Surgical intervention in infective endocarditis: indications and timing]. Harefuah (2005) 0.75
[Hepatorenal syndrome: pathogenesis and treatment]. Harefuah (2007) 0.75
Oral Administration of CardioAid and Lunasin Alleviates Liver Damage in a High-Fat Diet Nonalcoholic Steatohepatitis Model. Digestion (2017) 0.75